Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE  
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel,   BELGIË  
 
Tel: +32 229- 91111. Fax: +32 229- 64301. E -mail: COMP -MERGER -REGISTRY@ec.europa.eu.  
  EUROPEAN COMMISSION  
Brussels, 20.06.2022  
C(2022) 4326 final  
PUBLIC VERSION 
CVC Capital Partners SICAV -FIS S.A.  
20 Avenue Monterey  
L-2163 – Luxembourg  
Luxembourg  
 
Hartenberg Holding, s.r.o.  
Na příkopě 859/22, Nové Město  110 00 – Praha 1  
Czechia  
Subject : Case M. 10635 – CVC / HTB / FL  
Commission decision pursuant to Article 6(1)(b) of Council Regulation 
(EC) No  139/20041 and Article 57 of the Agreement on the European 
Economic Area2  
Dear Sir or Madam,  
1. On 20 May 2022, the European Commission received notification of a proposed 
concentration pursuant to Article 4 of the Merger  Regulation by which CVC Capital 
Partners SICAV -FIS S.A. ("CVC", Luxembourg) and Hartenberg Hold ing, s.r.o. 
("HTB", Czech Republic) will acquire  within the meaning of Article 3(1)(b) and 3(4) 
of the Merger Regulation joint control of FutureLife, a.s. ("FL", Czech Republic), 
controlled by HTB by way of purchase of shares .3 
2. The business activities of the undertakings concerned are  the following:  
− CVC, its subsidiaries and affiliated companies are privately owned entities whose 
activities include providing investment advice to and/or managing investments on 
behalf of certain investment funds and platform s. One of CVC’s portfolio 
companies, Mehiläinen, offers In- Vitro -Fertilization ("IVF") treatments in clinics 
in Finland , 
                                                 
1 OJ L 24, 29.1.2004, p. 1 ( the ‘Merger Regulation ’). With effect from 1 December 2009, the Treaty on 
the Functioning of the European Union ( ‘TFEU ’) has introduced certain changes, such as the 
replacement of ‘ Community ’ by ‘Union’  and ‘common market ’ by ‘internal market ’. The terminology 
of the TFEU will be used throughout this decision.  
2  OJ L 1, 3.1.1994, p. 3 ( the ‘EEA Agreement ’). 
3  Publication in the Official Journal of the European Union No C 218, 2.6.2022, p. 13.  

2 − HTB is a company focused on investments in assets in the Central European 
Region, primarily Czech Republic, Slovakia and Poland, and is  the current sole 
controlling shareholder of FL , 
− FL is active in the provision of reproductive medicine in various countries across 
Europe, in particular IVF treatment and ancillary services. FL’s business in 
Finland and Estonia will not form part of the proposed concentration, and will be 
transferred to, and remain solely controlled by, HTB.  
3. After examination of the notification, the European Commission has concluded that 
the notified operation falls within the scope of the Merger  Regulation  and of 
paragra ph 5(c ) of the Commission Notice on a simplified procedure for treatment of 
certain concentrations under Council Regulation (EC) No  139/2004.4 
4. For the reasons set out in the Notice on a simplified procedure, the European 
Commission has decided not to oppos e the notified operation and to declare it 
compatible with the internal market and with the EEA Agreement. This decision is 
adopted in application of Article 6(1)(b) of the Merger  Regulation and Article 57 of 
the EEA Agreement . 
For the Commission  
 
 
(Signed)  
Olivier GUERSENT  
Director -General  
                                                 
4  OJ C 366, 14.12.2013, p. 5.